Home > products > custom-nanocomposites
> lipid-nanoparticle-composite-materials
> dt-061-smap-liposomes-formulation-tt-40
DT-061 (SMAP) Liposomes, Formulation TT-40
DT-061 (SMAP) Liposomes, Formulation TT-40
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-R-5667 | 2mL | 985.00 | + Add to cart |
|
R-R-5667 | 10ml | 2985.00 | + Add to cart |
|
|
Product description
DT-061 (SMAP) Liposomes, Formulation TT-40. PEGylated liposomes containing PP2A activator DT-061 (SMAP). DT-061 is an activator of protein phosphatase 2A (PP2A). PP2A regulates many cellular signaling pathways including MAPK/ERK, Wnt/β-catenin, Akt/mTOR, GSK3β, p53/apoptosis, cell cycle, and others. This product can be used in vitro or in vivo for studying the effects of PP2A activation and could be applied to preclinical therapy of KRAS-mutant and MYC-driven tumors. The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.
Appearance | N/A |
---|---|
Concentration, Total Lipid | 60 mM |
Hydration Solution | 300 mM sucrose |
External Solution | 300 mM sucrose |
Average Size | 70-120 nm |
Storage | 2 °C to 8 °C (do not freeze) |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 6 months |
Document
Related Product